|
Cours en clôture
17/08/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
13,31 CNY
|
-1,63%
|
 |
+18,95%
|
+13,76%
|
|
26/05 |
Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement
| | |
25/05 |
Guizhou Sanli pharmaceutical to raise funds via private placement
| | |
25/05 |
Guizhou Sanli Pharmaceutical Co.,Ltd announced that it expects to receive CNY 700 million in funding
| | |
27/04 |
Guizhou Sanli Pharmaceutical Co.,Ltd announces Annual dividend, payable on June 30, 2026
| | |
26/04 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
26/04 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
23/04 |
Guizhou Sanli Pharmaceutical Co.,Ltd announced that it expects to receive CNY 300 million in funding
| | |
03/12 |
Sanli Pharma to Withdraw Stake in Associate; Shares Down 3%
| | |
27/10/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
12/09/25 |
Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
| | |
11/09/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback announced on September 12, 2024, has closed with 7,869,300 shares, representing 1.93% for CNY 99.95 million.
| | |
27/08/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
23/04/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd announces Annual dividend, payable on June 26, 2025
| | |
22/04/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
22/04/25 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
04/04/25 |
Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
| | |
03/01/25 |
Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
| | |
20/12/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd completed the acquisition of additional 22.91% stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Deng Daixing.
| | |
04/12/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd agreed to acquire an additional 22.91% stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Deng Daixing for approximately CNY 170 million
| | |
28/10/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
09/10/24 |
Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
| | |
20/09/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd agreed to acquire an additional 40% stake in Guizhou Sankang Enterprise Management Partnership Enterprise (Limited Partnership) from Guizhou Health Agriculture Chinese Medicine Food Material Development Group Co., Ltd. for CNY 40 million.
| | |
13/09/24 |
Guizhou Sanli Pharmaceutical Plans Up to 120-Million-Yuan Share Buyback
| | |
13/09/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 120 million worth of its shares.
| | |
12/09/24 |
Guizhou Sanli Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
